Ravichandran Ramasamy

16.0k citations
178 papers · 13.0k indexed · 3 hit papers · h-index 59
Topics
Advanced Glycation End Products research (77 papers)Cardiac Ischemia and Reperfusion (40 papers)Aldose Reductase and Taurine (34 papers)

In The Last Decade

Ravichandran Ramasamy

177 papers receiving 12.7k citations

Hit Papers

Glutaminolysis and Transferrin Regulate Ferro...200520262012201920152005201150010001.5k

Peers

Ravichandran Ramasamy
Comparison fields: 5 of 153
  • Clinical Biochemistry 5.2k
  • Molecular Biology 4.2k
  • Endocrinology, Diabetes and Metabolism 2.8k
  • Physiology 2.3k
  • Pulmonary and Respiratory Medicine 1.7k
Replace Michael Brownlee with:
Michael Brownlee United States
Erwin Schleicher Germany
Toshio Miyata Japan
Ronald G. Tilton United States
Sho‐ichi Yamagishi Japan
Suzanne R. Thorpe United States
Masayoshi Takeuchi Japan
Kumar Sharma United States
Ida Giardino Italy
Masakazu Haneda Japan
Ravichandran Ramasamy relative to Michael Brownlee United States Michael Brownlee's profile →
Citations per field
00.5×5.4×
Michael Brownlee · 1×
Citations per year

Countries citing papers authored by Ravichandran Ramasamy

Since Specialization
Citations

This map shows the geographic impact of Ravichandran Ramasamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravichandran Ramasamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravichandran Ramasamy more than expected).

Fields of papers citing papers by Ravichandran Ramasamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravichandran Ramasamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravichandran Ramasamy. The network helps show where Ravichandran Ramasamy may publish in the future.

Co-authorship network of co-authors of Ravichandran Ramasamy

This figure shows the co-authorship network connecting the top 25 collaborators of Ravichandran Ramasamy. A scholar is included among the top collaborators of Ravichandran Ramasamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravichandran Ramasamy. Ravichandran Ramasamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 7
3 4
4 5
5 12
6 13
7 15
8 45
9 20
10 136
11 18
12 3
13 56
14 13
15 133
16 42
17 132
18 357
19 138
20 4

About Ravichandran Ramasamy

Ravichandran Ramasamy is a scholar working on Clinical Biochemistry, Pathology and Forensic Medicine and Physiology, having authored 178 papers that have together received 13.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (77 papers), Cardiac Ischemia and Reperfusion (40 papers) and Aldose Reductase and Taurine (34 papers). The work is most often cited by research in Clinical Biochemistry (5.2k citations), Endocrinology, Diabetes and Metabolism (2.8k citations) and Physiology (2.3k citations). Ravichandran Ramasamy has collaborated with scholars based in United States, Portugal and Canada. Frequent co-authors include Ann Marie Schmidt, Shi Fang Yan, Nosirudeen Quadri, Minghui Gao, Xuejun Jiang, Prashant Monian, Radha Ananthakrishnan, Kevan C. Herold, Yoshifumi Naka and Saul Schaefer. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026